We are live on ! Find out more
BNTX icon

BioNTech

37 hedge funds and large institutions have $384M invested in BioNTech in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 1

95% more funds holding

Funds holding: 1937 (+18)

34% more capital invested

Capital invested by funds: $286M → $384M (+$98.2M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.82% less ownership

Funds ownership: 3.74%2.92% (-0.82%)

40% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 10

Holders
37
Holders Change
+18
Holders Change %
+94.74%
% of All Funds
0.82%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
6
Reduced
10
Closed
1
Calls
Puts
Net Calls
Net Calls Change

BNTX Hedge Fund Activity: Q1 2020 in Review

37 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q1 2020, worth a combined $384M — up 34% from $286M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BNTX positions and 1 closed out — a net gain of 18 holders — while 6 added to existing stakes and 10 trimmed.

The largest buyer was Primecap Management, adding an estimated $18.8M. The largest seller was Fidelity Investments, cutting an estimated $60.2M.

  • 37 institutional investors held BioNTech (BNTX) as of Q1 2020, up from 19 in Q4 2019.
  • Funds reported $384M of BioNTech stock for Q1 2020, up 34% quarter-over-quarter.
  • 19 funds opened new BioNTech positions in Q1 2020 and 1 closed out, a net change of +18 holders.
  • The largest BioNTech buyer in Q1 2020 was Primecap Management, an estimated $18.8M added.
  • The largest BioNTech seller in Q1 2020 was Fidelity Investments, an estimated $60.2M sold.

Based on aggregated 13F filings for Q1 2020.